Arecor Therapeutics (AREC) Competitors GBX 73.44 +1.44 (+2.00%) As of 09/18/2025 11:08 AM Eastern Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsHeadlinesInsider TradesBuy This Stock AREC vs. SCLP, MPH, OBI, ORPH, HVO, REDX, IMM, ETX, HEMO, and SBTXShould you be buying Arecor Therapeutics stock or one of its competitors? The main competitors of Arecor Therapeutics include Scancell (SCLP), Mereo BioPharma Group plc (MPH.L) (MPH), Ondine Biomedical (OBI), Open Orphan (ORPH), hVIVO (HVO), Redx Pharma (REDX), ImmuPharma (IMM), e-therapeutics (ETX), Hemogenyx Pharmaceuticals (HEMO), and SkinBioTherapeutics (SBTX). These companies are all part of the "biotechnology" industry. Arecor Therapeutics vs. Its Competitors Scancell Mereo BioPharma Group plc (MPH.L) Ondine Biomedical Open Orphan hVIVO Redx Pharma ImmuPharma e-therapeutics Hemogenyx Pharmaceuticals SkinBioTherapeutics Scancell (LON:SCLP) and Arecor Therapeutics (LON:AREC) are both small-cap medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their valuation, risk, profitability, institutional ownership, media sentiment, dividends, earnings and analyst recommendations. Which has more volatility and risk, SCLP or AREC? Scancell has a beta of 0.35, suggesting that its stock price is 65% less volatile than the S&P 500. Comparatively, Arecor Therapeutics has a beta of -0.18, suggesting that its stock price is 118% less volatile than the S&P 500. Do institutionals and insiders hold more shares of SCLP or AREC? 0.9% of Scancell shares are owned by institutional investors. Comparatively, 9.0% of Arecor Therapeutics shares are owned by institutional investors. 15.2% of Scancell shares are owned by insiders. Comparatively, 4.8% of Arecor Therapeutics shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term. Is SCLP or AREC more profitable? Scancell has a net margin of 0.00% compared to Arecor Therapeutics' net margin of -176.89%. Scancell's return on equity of 98.74% beat Arecor Therapeutics' return on equity.Company Net Margins Return on Equity Return on Assets ScancellN/A 98.74% -45.28% Arecor Therapeutics -176.89%-118.67%-37.31% Which has stronger valuation and earnings, SCLP or AREC? Scancell has higher earnings, but lower revenue than Arecor Therapeutics. Scancell is trading at a lower price-to-earnings ratio than Arecor Therapeutics, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioScancell£4.71M22.69-£6.75M-£0.02-495.19Arecor Therapeutics£5.05M5.49-£10.68M-£0.31-236.90 Does the media refer more to SCLP or AREC? In the previous week, Scancell had 7 more articles in the media than Arecor Therapeutics. MarketBeat recorded 7 mentions for Scancell and 0 mentions for Arecor Therapeutics. Scancell's average media sentiment score of 1.09 beat Arecor Therapeutics' score of 0.00 indicating that Scancell is being referred to more favorably in the media. Company Overall Sentiment Scancell Positive Arecor Therapeutics Neutral SummaryScancell beats Arecor Therapeutics on 9 of the 13 factors compared between the two stocks. Get Arecor Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for AREC and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding AREC and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart AREC vs. The Competition Export to ExcelMetricArecor TherapeuticsBiotechnology IndustryMedical SectorLON ExchangeMarket Cap£27.73M£237.84M£5.77B£2.58BDividend YieldN/A3.78%5.74%5.31%P/E Ratio-236.9041.0176.875,427.87Price / Sales5.494,907.50543.1897,460.81Price / Cash5.0713.1937.1727.93Price / Book4.43136.7513.839.27Net Income-£10.68M-£90.99M£3.29B£5.89B7 Day Performance-1.49%0.58%1.57%0.59%1 Month Performance14.09%19.80%6.87%3.21%1 Year Performance7.60%785.61%81.58%186.69% Arecor Therapeutics Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)ARECArecor TherapeuticsN/AGBX 73.44+2.0%N/A-3.4%£27.73M£5.05M-236.9010Gap UpSCLPScancellN/AGBX 9.15+2.8%N/A-32.7%£92.36M£4.71M-439.9051Insider TradeHigh Trading VolumeMPHMereo BioPharma Group plc (MPH.L)N/AN/AN/AN/A£89.76MN/A-0.2150Gap DownOBIOndine BiomedicalN/AC$15.00-3.2%N/A+181.8%C$80.35MC$2.05M-214.29N/ANews CoverageORPHOpen OrphanN/AN/AN/AN/A£67.09M£34.71M-25.30179HVOhVIVO1.8391 of 5 starsGBX 9.70+0.5%GBX 28+188.7%-66.1%£66.32M£62.73M625.81N/AREDXRedx PharmaN/AN/AN/AN/A£58.35M£4.20M-150.00101Gap UpHigh Trading VolumeIMMImmuPharmaN/AGBX 13.98+28.8%N/A+627.5%£54.22MN/A-1,570.6713Trending NewsGap UpHigh Trading VolumeETXe-therapeuticsN/AN/AN/AN/A£52.59M£295K-450.0035High Trading VolumeHEMOHemogenyx PharmaceuticalsN/AGBX 1,010+9.7%N/A+101,425.6%£51.67MN/A-557.7014News CoverageGap DownSBTXSkinBioTherapeuticsN/AGBX 16.43+1.1%N/A+53.5%£42.05M£2.68M-1,314.0011 Related Companies and Tools Related Companies Scancell Alternatives Mereo BioPharma Group plc (MPH.L) Alternatives Ondine Biomedical Alternatives Open Orphan Alternatives hVIVO Alternatives Redx Pharma Alternatives ImmuPharma Alternatives e-therapeutics Alternatives Hemogenyx Pharmaceuticals Alternatives SkinBioTherapeutics Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (LON:AREC) was last updated on 9/19/2025 by MarketBeat.com Staff From Our PartnersHe Called Nvidia at $1.10. Now, He Says THIS Stock Will…The original Magnificent Seven returned 16,894%—turning $7K into $1.18 million. Now, the man who called Nvi...The Oxford Club | SponsoredA New Way to Double Your Retirement Income?Bloomberg reports that a new class of investments is “entering a golden era,” with yields fueling a retail boo...Investors Alley | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredStrange crypto pattern discovered by 40-person research teamSomething unusual is happening inside a 40-person crypto research firm. They're helping 8,000+ ordinary peo...Crypto Swap Profits | SponsoredThis is the “End of Tesla” as we know it…Jeff has identified five of the past seven number-one performing tech stocks — before they took off. His Tesla...Brownstone Research | Sponsored“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredForget NVDA. Put $1,000 into this stock nowA massive money shift is underway in the AI market. And it's opening up an extraordinary opportunity in a NEW ...Chaikin Analytics | SponsoredForget Tesla — This Tiny AI Stock Is Musk’s Real PlayWhile Wall Street focused on Tesla’s earnings, Elon Musk was quietly building a supercomputer so powerful it c...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Arecor Therapeutics plc Please log in to your account or sign up in order to add this asset to your watchlist. Share Arecor Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free AREC Stock Alerts